Navigation Links
AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
Date:6/17/2013

AE that occurred within dose escalation to 1200mg.

Preliminary efficacy results demonstrated that 13 of 16 evaluable patients (81%) with 17p deletion achieved a response to ABT-199/GDC-0199. Specifically, 2 patients (12%) achieved a complete response (CR) or complete response with incomplete bone marrow recovery and 11 patients (69%) achieved a partial response (PR). Among the patients with F-refractory CLL, 14 of 18 evaluable patients (78%) achieved a response; 3 (17%) achieved a complete response or complete response with incomplete bone marrow recovery and 11 (61%) achieved a partial response.  These results are similar to the preliminary efficacy observed in the overall CLL study population (84 percent response rate). Further clinical studies to evaluate the efficacy and safety of ABT-199/GDC-0199 in CLL, and specifically in patients with high-risk CLL, are necessary.

NHL Arm
As of April 2013, 32 patients have enrolled in the NHL arm of the trial, and 12 are currently active. Patients were given a single oral dose (50-400mg) followed by six days without medication before being dosed with continuous once-daily dosing. Due to concerns over TLS, a dose-escalation protocol was implemented. Patients who were treated with up to 900mg have been evaluated to date. Single-agent activity was observed in the trial and warrants further clinical investigation. Dose escalation will continue to determine maximum-tolerated dose and optimal dosing regimen.

The most common hematological AEs during the study were neutropenia, thrombocytopenia (16% each), and anemia (13%). The most common non-hematological AEs were nausea (41%), diarrhea (28%), dyspepsia, vomiting, fatigue, pyrexia, upper respiratory tract infection and cough (19% each). Grade 3/4 thrombocytopenia, neutropenia and anemia occurred in four patients (13% each). Grade 3/4 thrombocytopenia was not dose dependent. TLS was seen after the initial dose in one patient with bulky mantle cell lym
'/>"/>

SOURCE AbbVie
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. AbbVie Named to S&P 500 Dividend Aristocrat Index
2. AbbVie Issues Inaugural Full-Year Outlook for 2013
3. AbbVie to Present at Barclays Global Health Care Conference
4. Receptos Licenses Anti-Interleukin-13 Antibody from AbbVie for Phase 2 Development in Orphan Disease
5. AbbVie to Host First-Quarter Earnings Conference Call
6. AbbVie Reports First-Quarter 2013 Financial Results
7. AbbVie CF Scholarship Application Now Available for Exceptional Undergraduate and Graduate Students with Cystic Fibrosis
8. AbbVies Investigational HCV Regimen Receives Breakthrough Therapy Designation from the U.S. Food and Drug Administration
9. AbbVie to Present at Bank of America Merrill Lynch 2013 Health Care Conference
10. AbbVie and Alvine to Collaborate on Investigational Oral Therapy for Celiac Disease
11. AbbVie to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... , Mexique, July 3, 2015 ... cible les épidémies que sont l,hypertension, le diabète ... l,intermédiaire de plateformes éducatives gratuites et d,une conférence ... (Photo: http://photos.prnewswire.com/prnh/20150630/227033 ) , ... en ligne , Prendre en charge l,hypertension ...
(Date:7/3/2015)... MUMBAI , July 3, 2015 /PRNewswire/ ... gab heute bekannt, vorbehaltlich bestimmter Abschlussbedingungen eine ... Russland erworben zu haben. Mit dieser Übernahme ... der mit einem Umsatz von 765 Mrd. ... größten Pharmamärkten der Welt gehörte (IMS Health). ...
(Date:7/3/2015)... STOCKHOLM , July 3, 2015 ... agreement with Broda Technologies Co., Ltd., operating in both ... use the company,s proprietary IntelliGel ® supramolecular hydrogel ... under development and other ophthalmic therapies. The Broda technology ... polymer solution is a free-forming liquid and with low ...
Breaking Medicine Technology:Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 3Lupin übernimmt Biocom aus Russland 2Lupin übernimmt Biocom aus Russland 3Redwood Pharma Licenses Novel Hydrogel Drug Delivery Technology From Broda Technologies 2
... Pa., Aug. 19 Particle Sciences Inc. ... and,pilot production capabilities with the installation of ... core of the pilot line,comprising a Haake ... enables the production of high-quality drug loaded ...
... samples to be used to identify molecular,signature of ... ALS Therapy,Development Institute (ALS TDI) announced today ... samples collected through an expanded network,of clinical partnerships. ... effort to indentify the altered expression of genes,and ...
Cached Medicine Technology:Particle Sciences Expands Its Combination Product Capabilities 2ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrig's Disease 2ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrig's Disease 3
(Date:7/3/2015)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, ... truth and expose popular lies regarding proper relationships according to the bible. ... into the core of the subject by explaining why certain types of sexual relationships ...
(Date:7/2/2015)... ... 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest ... Lone Star State. The premium frozen yogurt chain was listed as #22 on the Inc. ... in the Village at Bachman Lake, is located at:, 3701 W. Northwest Highway, STE 430, ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... retrofit project at the University of Minnesota, they knew it would save the ... also be an award-winning choice: the total energy savings after installation was an ...
(Date:7/2/2015)... ... July 02, 2015 , ... “ LIFX ” was featured on NewsWatch ... products available to consumers. Amanda Forstrom, a technology expert and special reporter for NewsWatch, ... versatile smart light bulbs on the market. , According to the U.S. Department of ...
(Date:7/2/2015)... ... July 02, 2015 , ... Six months ahead of his 80th birthday, ... raise awareness and money for the Pulmonary Hypertension Association (PHA). Stevenson began the ... near Washington, D.C. by mid-September. He left Glasgow, Mont. yesterday morning and is making ...
Breaking Medicine News(10 mins):Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:sweetFrog Opens 18th Location in the Lone Star State 2Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2Health News:The Most Versatile Smart Light Bulbs were featured on NewsWatch Television 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 3
... in an attempt to find out how various eating ... the blood pressures of meat eaters, fish eaters, vegetarians, ... Health Nutrition, showed how healthy eating habits could help ... in the comparative study - some with high blood ...
... on birth control pills have been linking them to ... pills. However, a new study published by Walter Spitzer, ... contradicted previous studies by stating that women who take ... no increased risk for heart attack compared to women ...
... observed a pill-sized camera and a CT scan may prove ... small intestine. The newly approved camera capsule, also known as ... before available. A patient swallows the pill and, for eight ... on the person's abdomen.// The pictures can then be viewed ...
... have discovered that it might be possible for tear-free GM ... the chemical in onions that makes you cry is not ... of Tokyo and Kyoto University,//tested the theory that the crying ... Alliinase plays a part in the chemical reactions that give ...
... that cloned animals tend to harbor genetic defects that ... the rational that reproductive cloning of humans should be ... be used safely for therapeutic cloning techniques, such as ... Parkinson's to diabetes. Cloned animals have major ...
... shown in a new study, that soy can lower cholesterol ... studies give more reason to dish up the soy protein ... fatty acids, which are found in abundance in fish, //flax ... health benefits. But researchers suggest they also produce physiological effects ...
Cached Medicine News:Health News:Cut meat to cut blood pressure 2Health News:No heart attack risk for women taking birth control pills 2Health News:Genetic failure in cloned animals 2Health News:Soy, Omega 3s convalesce artery health 2Health News:Soy, Omega 3s convalesce artery health 3
They employ Lea Symbols. Contrast levels are the same at 25%, 10%, 5%, 2.5% and 1.25%. Each offers a different set of Lea Symbols to guard against memorization. Also uses recording forms (P/N 215400)...
Binkhorst Hook (Left) 2.5 mm wide J Shape (0.64 mm x 25 mm)....
McIntyre-Binkhorst, length 18 mm....
Set of 2. Double-ended. 15 mm x 21 mm and 15 mm x 42 mm blades. Hand-held. Most popular model or size....
Medicine Products: